Bone Health Technologies, a medical technology startup developing non-pharmacological solutions for bone health, has launched Osteoboost, an FDA-cleared prescription wearable device for postmenopausal women with osteopenia. The device is available for pre-order; shipments are expected within 60–90 days.

Osteoboost is a waist-worn device that delivers targeted hip and spine vibration therapy. The device uses a patented combination of dynamically calibrated frequency and amplitude, can be used during daily activities like walking or household chores, and features auto-calibrated mechanical vibrations within the therapeutic frequency range.

According to clinical trials conducted at the University of Nebraska Medical Center, Osteoboost reduces the loss of spinal bone density by 85% and bone strength by 83%. The device offers a safe, convenient, and non-invasive alternative to traditional treatments for maintaining bone health.

Analyst QuickTake: In July , the company acquired Wellen, a Brooklyn-based company focused on personalized exercise programs for osteoporosis, for an undisclosed sum. At the time of the acquisition, Bone Health Technologies noted that it would integrate Wellen’s expertise with its FDA-cleared Osteoboost vibration therapy belt before launching the device. This could include learnings from Wellen’s personalized, science-backed exercise programs for women over 50 to address osteoporosis, which might make Osteoboost a more holistic therapeutic offering.